Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
Flash
13:00
Crescent Biopharma Inc recently disclosed that certain revenues recognized in its 2025 financial report actually originate from a $20 million upfront payment made by Kelun-Biotech under a licensing agreement between the two parties for the core asset Cr-001.
This financial arrangement highlights the commercial value of the Cr-001 project and the recognition from its partners. The confirmation of this funding strictly follows relevant accounting standards, reflecting the direct contribution of the authorized transaction to Crescent Biopharma's short-term financial performance.
13:00
Installed Building Products (IBP) recently released an industry outlook, indicating that residential construction activity is expected to continue facing challenges in the short term.
However, the company remains optimistic about the long-term prospects of its installation services. Despite the current market uncertainties, IBP emphasizes that the fundamentals of its core business—professional installation services—remain solid. In the long run, as housing demand gradually releases and construction standards improve, the installation services market is expected to achieve steady growth.
13:00
Matador Resources recently announced the official launch of a cash tender offer for its outstanding 6.875% senior notes due 2028.
The offer aims to repurchase all outstanding notes of this type, demonstrating the company's strategic intention to actively manage its debt structure. Through this initiative, Matador Resources is expected to optimize its capital allocation and reduce overall financial costs. Market observers believe that such proactive debt management actions typically reflect a company's robust cash flow and confidence in its future financial health.
News